Our research focuses on overcoming the ongoing challenges in cancer therapy. The main emphasis of the research is to develop new biomedical and pharmaceutical nanotechnology strategies to achieve the critical issues in cancer chemo-immunotherapy. Our research activities are in the following areas:

• Formulation and characterization of polymeric nanomaterials and protein therapeutics

• siRNA/Oligonucletide delivery in cancer treatment

• Targeted delivery systems for pharmaceutical applications (topical, iv. or sc. administration)

• Receptor-mediated nanoparticles for vaccine delivery

• Receptor-based tumor targeting for chemotherapy